Develops antibody-drug conjugates for head and neck cancer.
Dec 2025Revenue $13.9M/yrExpenses $98.3M/yr
No trendCash runway ≈ 6 months from Jun 2026
Figures by year
When will Pyxis Oncology be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $13.9M and expenses $98.3M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $13.9M | $98.3M | −$84.4M |
| Dec 2024 | $16.1M | $106M | −$89.5M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.